#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leukodystrophy Sarcoidosis Vulval cancer recurrent Liposarcoma recurrent Small for dates baby Hyperinsulinaemic hypoglycaemia Conjunctivitis allergic Isodicentric chromosome 15 syndrome Chondrosarcoma Gastrointestinal stromal tumour Cluster headache Measles Paraneoplastic neurological syndrome Pleural mesothelioma Small cell lung cancer recurrent More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis – Life with Disease Alport’s syndrome – Diagnostics Primary mediastinal large B-cell lymphoma – Trials in Disease Urea cycle disorder – Diagnostics Gaucher’s disease type I – Life with Disease Rhabdomyosarcoma recurrent – Treatment SAPHO syndrome – Life with Disease Medulloblastoma recurrent – Diagnostics Waldenstrom’s macroglobulinaemia refractory – Life with Disease Biotinidase deficiency – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Brigatinib Lolium Perenne CARBOMER 980 Esketamine Tebentafusp Amikacin Durvalumab Dorocubicel Epinephrine Heparin Sodium Dexmedetomidine Imidapril Hydrochloride Sonelokimab Tin816 Alx148 Art0380 Mesilate Valsartan Florquinitau (18F) Loperamide Hydrochloride Tng462 More therapies…

    Learn about Your Condition

    Tendon injury Eosinophilic gastritis Genital infection female Venous thrombosis limb Hodgkin's disease Pulmonary resection Gender dysphoria Tubulointerstitial nephritis Mucopolysaccharidosis III Extra-osseous Ewing's sarcoma Keratosis follicular Hepatitis alcoholic Brain injury Palmoplantar pustulosis Coronary artery occlusion More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Universitaire Rouen

Centre Hospitalier Universitaire Rouen

1 Rue De Germont, Bp 96031, Rouen, 76031, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness of Mesenchymal Stromal Cells in Children with Steroid-Refractory Acute Graft-Versus-Host Disease

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Anti-T Lymphocyte Immunoglobulin For Human Use, Rabbit
    • Etanercept
    • Infliximab
    France Germany Italy Poland Spain
  • Study of Upadacitinib and Topical Corticosteroids for Adolescents and Adults with Moderate to Severe Eczema

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Fluocinolone Acetonide
    • Hydrocortisone
    • Pimecrolimus
    Austria Belgium Bulgaria Croatia Czechia Finland +12
  • Study of Pembrolizumab with Chemotherapy for Patients with Resectable Stage II, IIIA, and IIIB Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Cisplatin
    • Gemcitabine
    • Pembrolizumab
    Belgium Estonia France Germany Ireland Italy +5
  • Study on the Effects of LEO 138559 for Adults with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Humanised Igg1 Monoclonal Antibody Against Interleukin 22 Receptor Subunit Alpha
    Czechia France Germany Hungary Poland Romania +1
  • Study Comparing Upadacitinib and Adalimumab for Adults with Moderate to Severe Rheumatoid Arthritis Not Responding to a Single TNF Inhibitor

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Adalimumab
    • Upadacitinib
    Belgium Bulgaria Croatia France Germany Greece +5
  • Study on BP1.4979 for Treating Binge Eating Disorder in Women with Moderate to Severe Symptoms

    Not recruiting

    2 1
    Investigated Diseases:
    • Binge eating
    Investigated Drugs:
    • N-[4-[2-[4-(3-Cyanophenyl)Piperazin-1-Yl]Ethyl]Cyclohexyl]-3-Methoxypropanamide
    France Spain
  • Study on Tegoprubart for Preventing Kidney Transplant Rejection in Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Kidney transplant rejection
    Investigated Drugs:
    • Antithymocyte Immunoglobulin
    • At-1501
    • Mycophenolate Mofetil
    France Germany Spain
  • Study on the Safety and Tolerance of BI 1291583 in Adults with Cystic Fibrosis Bronchiectasis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Bronchiectasis
    • Cystic fibrosis
    Investigated Drugs:
    • Bi 1291583
    • Salbutamol Sulfate
    Belgium France Germany Italy The Netherlands Spain
  • Study of Volrustomig with Carboplatin and Pemetrexed for Patients with Unresectable Pleural Mesothelioma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Pleural mesothelioma
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Infliximab
    Belgium Denmark France Germany Italy The Netherlands +3
  • Study on the Effects of Tigulixostat and Allopurinol in Patients with Gout and High Uric Acid Levels

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Allopurinol
    • Autumn Crocus Fresh Flower Fluid Extract (1:15-25), Extraction Solvent Ethanol 96% (V/V)
    • Naproxen
    Belgium Bulgaria Czechia France Germany Italy +3
Previous Page
1 … 41 42 43 44 45 … 48
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!